OOIR: Observatory of International Research

Papers

(The H4-Index of Frontiers in Neurology is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains	269
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide	196
Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery	182
Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review	143
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation	128
The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease	115
Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis	110
Cognitive Impairment After COVID-19—A Review on Objective Test Data	107
The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies	106
Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening	103
Deep Convolutional Neural Network-Based Epileptic Electroencephalogram (EEG) Signal Classification	101
Telemedicine and Virtual Reality for Cognitive Rehabilitation: A Roadmap for the COVID-19 Pandemic	100
Surface EMG in Clinical Assessment and Neurorehabilitation: Barriers Limiting Its Use	99
Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis	95
Comorbidity in Multiple Sclerosis	85
Exploring Sphingolipid Implications in Neurodegeneration	83
Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis	81
Clinical and Imaging Markers of Prodromal Parkinson's Disease	79
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management	78
Hemorrhagic Transformation in Ischemic Stroke and the Role of Inflammation	75
Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes	74
Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	74
Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review	73
The Regulation of microRNAs in Alzheimer's Disease	71
The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?	70

Challenges to the Emergence of Telerehabilitation in a Developing Country: A Systematic Review	68
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes	64
Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium	64
Effects of COVID-19 Pandemic Confinement in Patients With Cognitive Impairment	64
The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review	64
Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations	63
Therapeutic Plasticity of Neural Stem Cells	62
Intrinsically Photosensitive Retinal Ganglion Cells of the Human Retina	62
Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient	61
AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis	61
Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)	61
Seizure Diaries and Forecasting With Wearables: Epilepsy Monitoring Outside the Clinic	60
Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients	60
Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities	60
A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms	59
The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis	59
The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder	59
Effects of Probiotics on Depressive or Anxiety Variables in Healthy Participants Under Stress Conditions or With a Depressive or Anxiety Diagnosis: A Meta-Analysis of Randomized Controlled Trials	59
Gut Microbiota in Acute Ischemic Stroke: From Pathophysiology to Therapeutic Implications	59
Analysis and Biophysics of Surface EMG for Physiotherapists and Kinesiologists: Toward a Common Language With Rehabilitation Engineers	59
Giving Researchers a Headache – Sex and Gender Differences in Migraine	58
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study	58
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study	58
COVID-19 Dysautonomia	57
The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis	57
Assessment Methods of Post-stroke Gait: A Scoping Review of Technology-Driven Approaches to Gait Characterization and Analysis	57
Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging	57
Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients	57
Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury	56
The Lighting Environment, Its Metrology, and Non-visual Responses	55
A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS	55